CAS 62568-57-4 Delta Sleep Inducing Peptide For Muscle Building

Muscle Building DSIP Peptides Delta Sleep Inducing CAS 62568-57-4 High Purity Safe Pass

Abstract

DSIP Is An Amphiphilic Peptide Of Molecular Weight 850 Daltons With The Amino Acid Motif: N-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-C.

Delta Sleep-Inducing Peptide, Abbreviated DSIP, Was First Discovered In 1974 By The Swiss Schoenenberger-Monnier Group Who Isolated It From The Cerebral Venous Blood Of Rabbits In An Induced State Of Sleep. It Was Primarily Believed To Be Involved In Sleep Regulation Due To Its Apparent Ability To Induce Slow-Wave Sleep In Rabbits, But Studies On The Subject Have Been Contradictory.

It Has Been Found In Both Free And Bound Forms In The Hypothalamus, Limbic System And Pituitary As Well As Various Peripheral Organs, Tissues And Body Fluids.[3] In The Pituitary It Co-Localises With Many Peptide And Non-Peptide Mediators Such As Corticotropin-Like Intermediate Peptide (CLIP), Adrenocorticotrophic Hormone (ACTH), Melanocyte-Stimulating Hormone (MSH), Thyroid-Stimulating Hormone (TSH) And Melanin Concentrating Hormone (MCH). It Is Abundant In The Gut Secretory Cells And In The Pancreas Where It Co-Localises With Glucagon.

Background And Objective

Delta sleep-inducing peptide (DSIP) is an endogenous peptide that crosses the blood-brain barrier, named after its association with natural sleep and enhanced electroencephalogram (EEG) delta rhythm. The objective of this study was to determine whether DSIP could be used as an adjunct to volatile anaesthesia in humans, our hypothesis being that DSIP is a natural hypnotic that would increase anaesthetic depth. The aims were to assess depth of anaesthesia using bispectral index (BIS), the EEG and heart rate variability (HRV), and to determine whether DSIP altered the symmetry of EEG between the left and right cerebral hemispheres.

Function

Many roles for DSIP have been suggested following research carried out using peptide analogues with a greater molecular stability and through measuring DSIP-like immunological (DSIP-LI) response by injecting DSIP antiserum and antibodies.

Roles In Endocrine Regulation

Decreases basal corticotropin level and blocks its release.
Stimulates release of luteinizing hormone (LH).
Stimulates release of somatoliberin and somatotrophin secretion and inhibits somatostatin secretion.

High Purity Polypeptides